Skip to content

Effcacy of lacosomide on refractory focal seizures

Effcacy of lacosomide on refractory focal seizures as add on therapy in children aged 6 months to 16 years

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211104052968N1
Enrollment
44
Registered
2021-11-13
Start date
2020-12-30
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seizure. ICD-10-CM

Interventions

Intervention group:.

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 16 Years

Inclusion criteria

Inclusion criteria: All children from 6 months to 16 years of age with focal seizures who have been diagnosed with at least one previous electroencephalogram and do not respond well to routine treatments despite appropriate treatment with at least two anticonvulsants within 8 weeks of enrollment. They have had at least two relapses in four weeks and have not been in complete control for three weeks, and have not changed their doses of other anticonvulsant drugs in the two weeks prior to enrollment.

Exclusion criteria

Exclusion criteria: Previous administration of lacosamide as an anticonvulsant for at least two months prior to the examination renal deaseies Inability to tolerate the drug due to side effects Seizures caused by a progressive brain or neurodegenerative disease

Design outcomes

Primary

MeasureTime frame
Reducing the severity and severity of seizures in children 6 months to 16 years according to the definition of refractory seizures in Nelson's book. Timepoint: Patients' seizures were monitored after the drug reached the therapeutic dose, which is six weeks, and then three months later. Method of measurement: The severity of seizures as a percentage and includes 8 categories 0 - 25, 25-50, 50 to 75 and 75 to 100% in the range of negative to positive 100% based on the initial rate of seizures.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTaybeh Mohammadi

Esfahan University of Medical Sciences

dr.t.mohammadi2020@gmail.com+98 81 7467 3461

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026